Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 64Other hematologic neoplasm 57Myeloid 26Classical hematology 17Sarcoma 16Plasma cell 15Genitourinary 8Dermatologic 8CNS 7Gynecologic 5Breast 4Other neoplasm 2Gastrointestinal 2Thoracic 1Head & Neck 1

Conditions

Radiation Injuries 1Nasopharyngeal Carcinoma 1

Interventions

Cisplatin 263Radiotherapy 166Cetuximab 159Docetaxel 105Fluorouracil 104pembrolizumab 94Radiotherapy, Intensity-Modulated 83Carboplatin 80Paclitaxel 73Nivolumab 59Erlotinib Hydrochloride 35Surveys and Questionnaires 32Gemcitabine 32durvalumab 30Radiation 29Drug Therapy 25Immunohistochemistry 21Gefitinib 21Capecitabine 21tremelimumab 18Bevacizumab 18Surgical Procedures, Operative 17Sorafenib 17Magnetic Resonance Spectroscopy 17Ipilimumab 17Pemetrexed 16lenvatinib 15atezolizumab 15Radiosurgery 15Gene Expression Profiling 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Methylprednisolone × Head & Neck × Clear all
NCT01621880 2019-01-09

BRAIN

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Completed
112 enrolled 10 charts
Head & Neck

Nasopharyngeal Carcinoma, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡